Skip to content

Trial Summary

ACTICCA-1 is a clinical research study for people who have a cancer of the biliary tract (cancer of the gall bladder or bile duct, also known as cholangiocarcinoma in medical terms) which has been removed in an operation.

Acronym:

ACTICCA-1

ACTRN/NCT /ethics:

ACTRN12615001283561

Scientific title:

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)

Sponsor / Cooperative group:

Universitsklinikum Hamburg-Eppendorf

Trial & Patient Characteristics

Cancer TypeOther
Trial TypeTreatment
PhasePhase III
Age Range18 years and older
SexBoth
Tumour Stream Gall Bladder
Cancer StageAll stages
Anticipated Start Date2014-04-01
Anticipated End Date2022-04-01

Participating Hospitals

HospitalFlinders Medical Centre
Clinical Trial CoordinatorAlex Scott-Hoy
Emailalex.scott-hoy@sa.gov.au
Phone08 8204 4830
Principal InvestigatorProfessor Chris Karapetis
Recruitment StatusRecruiting